HB2291 Summary

• Removes the January 1, 2020 effective date language from electronic prescribing requirements for schedule II opioid controlled substances, making the requirement permanent.

• Modifies the red cap requirement for schedule II opioid containers dispensed by pharmacists to allow the board or executive director to waive the requirement if implementation is not feasible due to specific dosage forms or packaging types.

• Clarifies language throughout section 36-2525 Arizona Revised Statutes by replacing "permits" with "allows" and "No" with "not" for consistency in controlled substance prescription and recordkeeping provisions.